Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradation
US11033582B1 · kind B1 · utility
1Cited by
141References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2020 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Sep 15, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Systems and methods for acquiring, preserving, and administering delipidated plasma. Extracted delipidated plasma, comprising pre-beta HDL, is obtained and are spot tested to establish baseline amounts or concentrations of pre-beta HDL. The batches are subjected to preservation, stored, and then prepared again for use at some later date. A portion of the batch may be tested again to determine if the pre-beta HDL in the delipidated plasma has degraded or is no longer effective.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.